Berman Capital Advisors’s Bio-Techne TECH Stock Holding History

Berman Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$62K	Buy	512 +176	+52%	+$21.4K	0.01%	593
2021 Q2	$37K	Buy	336 +228	+211%	+$24K	0.01%	693
2021 Q1	$10K	Hold	108	–	–	﹤0.01%	1039
2020 Q4	$8K	Hold	108	–	–	﹤0.01%	1017
2020 Q3	$6K	Hold	108	–	–	﹤0.01%	990
2020 Q2	$7K	Buy	108 +20	+23%	+$1.2K	﹤0.01%	903
2020 Q1	$4K	Hold	88	–	–	﹤0.01%	970
2019 Q4	$4K	Hold	88	–	–	﹤0.01%	1046
2019 Q3	$4K	Hold	88	–	–	﹤0.01%	1024
2019 Q2	$4K	Hold	88	–	–	﹤0.01%	1036
2019 Q1	$4K	Hold	88	–	–	﹤0.01%	941
2018 Q4	$3K	Buy	+88	New	+$3.68K	﹤0.01%	821

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Berman Capital Advisors's TECH Position: Q3 2021 in Review

Berman Capital Advisors increased its Bio-Techne (TECH) stake by 52% in Q3 2021, buying an estimated $21.4K and bringing the position to 512 shares worth $62K. The position accounts for 0.01% of the portfolio, ranked #593.

Berman Capital Advisors first reported a position in TECH in Q4 2018 and has held it in 12 quarters since. 566 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

Berman Capital Advisors held 512 shares of Bio-Techne worth $62K as of Q3 2021.
Berman Capital Advisors bought 176 Bio-Techne shares in Q3 2021, an estimated $21.4K.
Bio-Techne made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #593 holding.
Berman Capital Advisors first reported a position in Bio-Techne in Q4 2018 and has held it in 12 quarters since.
566 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.